A new study has found small amounts of liquid ketamine administered in a clinical setting can significantly reduce symptoms ...

The U.S. Food and Drug Administration recently expanded approval of the nasal spray SPRAVATO, a ketamine-derived drug, as a treatment for depression. A clinic in Denver is looking to help those ...

Ketamine therapy has become known for its effects at combating depression and other mood disorders. There’s a growing body of ...

Researchers at the University of Virginia Brain Institute and UVA School of Medicine will conduct a trial to see if the ...

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

It has been claimed that former adult star Emily Willis, 25, is now "permanently disabled" and in a semi-conscious state ...

Respondents who said they used other drugs recreationally were also likelier to say they used ketamine during the past year ...

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

A new UniSC study has found small amounts of liquid ketamine administered in a clinical setting can significantly reduce symptoms of post-traumatic ...

Because it is still awaiting approval, Medicare does not typically cover the use of ketamine infusion for treating mental ...

An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a ...